These hematopoietic stem cells are derived from peripheral blood, following mobilization.
The Miltenyi Biotec CliniMACS CD3 depletion system is used to derive a defined allogeneic graft highly enriched with CD34+ hematopoietic cells and deplete of CD3+ T-lymphocytes from granulocyte colony-stimulating factor-mobilized, donor-derived peripheral blood stem cells.